Skip to main content
Watch Insiders
AVTXHealthcare

Avalo Therapeutics Inc (AVTX) Insider Trading

In the last 90 days, 3 Avalo Therapeutics Inc (AVTX) insiders reported no open-market purchases and 7 sales totaling $1,931,486. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 16, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 16, 2026Christopher Ryan SullivanChief Financial OfficerSale12,394$16.33$202,437
Sep 10, 2026Christopher Ryan SullivanChief Financial OfficerSale10,185$17.62$179,457
Aug 28, 2026Mittie DoyleChief Medical OfficerSale679$20.00$13,580
Aug 18, 2026Christopher Ryan SullivanChief Financial OfficerSale72,725$19.94$1,450,420
Aug 17, 2026Mittie DoyleChief Medical OfficerSale1,000$20.00$20,000
Aug 11, 2026Jennifer RileyChief Strategy OfficerSale2,655$19.59$52,012
Aug 10, 2026Mittie DoyleChief Medical OfficerSale679$20.00$13,580
Jul 27, 2026Mittie DoyleChief Medical OfficerSale1,000$20.00$20,000
Jun 30, 2026Mittie DoyleChief Medical OfficerSale4,654$20.00$93,080
Jun 23, 2026Mittie DoyleChief Medical OfficerSale1,450$18.00$26,100
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

AVTX insider trading FAQ

Are AVTX insiders buying or selling?
Over the last 90 days, AVTX insiders were net sellers, reporting $0.00 of open-market purchases and $1,931,486 of sales.
When was the last AVTX insider purchase?
No open-market insider purchase of Avalo Therapeutics Inc stock was reported in the last 90 days.
Where does AVTX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Avalo Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.